Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes

NCT03091517 is registered in ClinicalTrials.gov with Duke-NUS Graduate Medical School as lead sponsor.

NCT NCT03091517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03091517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes
Lead sponsor
Duke-NUS Graduate Medical School
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2017
Completion date
May 28, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus